Skip to main content
logo
Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
9.07
+0.20 (2.25%)
At close: Oct 12, 2026, 4:00 PM EDT
9.07
0.00 (0.00%)
After-hours: Oct 12, 2026, 4:00 PM EDT

Benitec Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
3164603076579
Market Cap Growth
-14.51%49.66%369.05%881.17%-29.60%-71.60%
Enterprise Value
1372762055212
Last Close Price
9.0713.3811.706.994.0519.72

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
----88.98129.85
PB Ratio
1.762.603.161.3933.043.29
P/TBV Ratio
1.792.603.161.3933.043.29

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
----9.9423.51

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
0.000.000.010.012.770.28
Net Debt / Equity Ratio
-1.01-1.01-1.00-1.07-9.49-1.13
Net Debt / EBITDA Ratio
3.513.512.322.260.100.18
Net Debt / FCF Ratio
10.7810.784.112.580.110.20
Asset Turnover
----0.010.01
Quick Ratio
33.6833.6854.2610.380.641.61
Current Ratio
34.0034.0054.6710.490.941.90
Return on Equity (ROE)
-33.21%-33.21%-52.46%-91.68%-1268.61%-159.08%
Return on Assets (ROA)
-22.67%-22.67%-34.39%-49.60%-228.53%-81.59%
Return on Capital Employed (ROCE)
-28.90%-28.90%-42.70%-47.60%-3926.10%-518.90%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-14.40%-9.91%-12.35%-33.22%-293.13%-192.09%
FCF Yield
-5.25%-3.62%-7.69%-29.91%-269.92%-167.86%
Buyback Yield / Dilution
-28.58%-28.58%-97.17%-1225.17%-188.30%-90.24%
SEC Filings: 10-K · 10-Q